Skip to content

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.: 10-Q filed 2015-01-20

What PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. reported in its quarterly report filed 2015-01-20 (fiscal Q2 2015): 18 published measures, 52 facts as tagged in accession 0001262463-15-000033.

This filing

Form
10-Q (quarterly report)
Filed
2015-01-20
Fiscal period
fiscal Q2 2015
Accession
0001262463-15-000033 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-11-3089,534USD
At 2014-05-31110,683USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-11-30-1,571,760USD
At 2014-05-31-1,493,489USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-11-304,408USD
At 2014-05-318,532USD
At 2013-11-3010,735USD
At 2013-05-3113,251USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-41,264USD91
2014-06-01 to 2014-11-30-84,458USD183
2013-09-01 to 2013-11-30-35,321USD91
2013-06-01 to 2013-11-30-103,069USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-06-01 to 2014-11-30-4,398USD183
2013-06-01 to 2013-11-30-2,350USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-11-30-3,315,365USD
At 2014-05-31-3,230,908USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-09-01 to 2014-11-3017,652,082shares91
2014-06-01 to 2014-11-3017,652,082shares183
2013-09-01 to 2013-11-3016,652,082shares91
2013-06-01 to 2013-11-3016,652,082shares183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-40,683USD91
2014-06-01 to 2014-11-30-82,947USD183
2013-09-01 to 2013-11-30-34,798USD91
2013-06-01 to 2013-11-30-109,493USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-11-304,408USD
At 2014-05-318,532USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-580USD91
2014-06-01 to 2014-11-30-1,559USD183
2013-09-01 to 2013-11-30-523USD91
2013-06-01 to 2013-11-30-1,290USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-11-301,661,295USD
At 2014-05-311,604,174USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-09-01 to 2014-11-3040,683USD91
2014-06-01 to 2014-11-3082,947USD183
2013-09-01 to 2013-11-3034,798USD91
2013-06-01 to 2013-11-30109,493USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-09-01 to 2013-11-301,263USD91
2013-06-01 to 2013-11-3022,641USD183

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-11-301,705,628USD
At 2014-05-311,705,628USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-11-3020,325USD
At 2014-05-3114,138USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-34,968USD91
2014-06-01 to 2014-11-30-78,271USD183
2013-09-01 to 2013-11-30-33,258USD91
2013-06-01 to 2013-11-30-103,069USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-09-01 to 2014-11-302,171USD91
2014-06-01 to 2014-11-305,922USD183
2013-09-01 to 2013-11-302,535USD91
2013-06-01 to 2013-11-307,146USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-09-01 to 2014-11-308,512USD91
2014-06-01 to 2014-11-3017,025USD183

Inspect the source

Entity
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. / CIK 0001350156
Captured
2026-09-20T07:55:09.049Z
SEC response SHA-256
691674f83316d1b4545916590a857835c154297d6df784a1ac8fcfb71be05c0e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001350156.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))